• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.00% Nasdaq Up0.38%

    AMAG Pharmaceuticals, Inc. (AMAG)

    -NasdaqGS
    66.18 Down 1.65(2.43%) May 21, 4:00PM EDT
    Add to Portfolio
    ProfileGet Profile for:
    AMAG Pharmaceuticals, Inc.
    1100 Winter Street
    Waltham, MA 02451
    United States - Map
    Phone: 617-498-3300
    Fax: 617-499-3361
    Website: http://www.amagpharma.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Diagnostic Substances
    Full Time Employees:257

    Business Summary 

    AMAG Pharmaceuticals, Inc. operates as a specialty pharmaceutical company that focuses on maternal health, anemia, and cancer supportive care. It markets Makena, a hydroxyprogesterone caproate injection to reduce the risk of preterm birth in women with a singleton pregnancy; Feraheme (ferumoxytol) injection for use as an intravenous (IV) iron replacement therapy for the treatment of iron deficiency anemia in adult patients with chronic kidney disease; and MuGard Mucoadhesive Oral Wound Rinse for the management of oral mucocitis/stomatiits and various types of oral wounds. The company markets Feraheme in the United States and Canada; and as Rienso in the European Union. It sells Feraheme to authorized wholesalers and specialty distributors. The company was founded in 1981 and is headquartered in Waltham, Massachusetts.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on AMAG Pharmaceuticals, Inc.

    Corporate Governance 
    AMAG Pharmaceuticals, Inc.’s ISS Governance QuickScore as of May 1, 2015 is 5. The pillar scores are Audit: 2; Board: 1; Shareholder Rights: 7; Compensation: 6.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
     PayExercised
    Dr. William K. Heiden , 55
    Chief Exec. Officer and Director
    1.12M0.00
    Mr. Frank E. Thomas , 45
    Pres and Chief Operating Officer
    764.00K0.00
    Mr. Scott A. Holmes M.S., M.B.A., CPA, 40
    Chief Accounting Officer, Sr. VP of Fin. & Investor Relations and Treasurer
    458.00K0.00
    Mr. Scott B. Townsend Esq., J.D., 48
    Sr. VP of Legal Affairs, Gen. Counsel and Sec.
    542.00K0.00
    Mr. Edward P. Jordan , 47
    Sr. VP of Sales & Marketing
    423.00K0.00
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders